Baudax Bio Inc reports results for the quarter ended in March - Earnings Summary

Baudax Bio

05/05/2021 14:41

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted loss
of 27 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 19 cents per share.
* Revenue was $198.00 thousand​​;  analysts expected $633.33
thousand.
* Baudax Bio Inc's reported EPS for the quarter was a loss of 27
cents​.
* The mean earnings estimate of analysts had risen by
about 25.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Baudax Bio Inc shares had fallen by 18.6% this quarter and
gained 4.0% so far this year.
* The company reported a quarterly loss of $16.91 million.
* Wall Street's median 12-month price target for Baudax Bio Inc
is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 5 at 01:41 p.m. GMT. ​All
figures in US Dollars.​